Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
Allogene Therapeutics, Inc. (ALLO)
Sector: Healthcare; Industry: Biotechnology

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is developing UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate, which is in Phase I clinical trials for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL; ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-08-16 Bhavnagri Veer General Counsel Sell 5,000 $21.00 $104,994 Yes
2021-06-15 Bhavnagri Veer General Counsel Sell 5,000 $25.32 $126,600 Yes
2021-05-18 Bhavnagri Veer General Counsel Sell 5,000 $30.00 $150,000 Yes
2021-04-15 Bhavnagri Veer General Counsel Sell 10,000 $32.05 $320,517 Yes
2021-03-15 Bhavnagri Veer General Counsel Sell 16,623 $37.95 $630,798 Yes
2020-10-06 Bhavnagri Veer General Counsel Sell 10,000 $40.00 $400,000 Yes
2020-10-01 Bhavnagri Veer General Counsel Sell 25,000 $36.52 $912,913 Yes
2020-09-01 Bhavnagri Veer General Counsel Sell 25,000 $35.36 $883,966 Yes
2020-08-03 Bhavnagri Veer General Counsel Sell 31,553 $36.89 $1,164,121 Yes

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.